Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener klinische Wochenschrift
Erschienen in:

01.09.2013 | original article

Upper urothelium carcinomas in Croatian endemic area

verfasst von: Ante Cvitković, PhD, MD, Igor Ivić-Hofman, MD, Dragana Jurić

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 17-18/2013

Einloggen, um Zugang zu erhalten

Summary Background/Aims Methods Results Conclusions

Endemic nephropathy (EN) is a chronic tubulointerstitial disease. Strong association between EN and urothelial carcinoma was noted as early as 40–50 ago. The aim of the study was to determine and compare specific mortality and morbidity of renal pelvis and ureter (upper urothelium) carcinoma (UUC) among Croatia as a whole, Brod-Posavina County, and Croatian endemic area.
Data on UUC mortality and morbidity were analyzed. Indirect standardization was employed on data comparison by calculating standardized mortality ratio and morbidity ratio.
Our study results showed the specific mortality rate in the endemic area to be 26.3-fold and 7.3-fold the rate recorded in Croatia and Brod-Posavina County, respectively. The mean standardized mortality ratio obtained by indirect standardization yielded an 8-fold and 32-fold risk of death from UUC in the endemic area vs. Brod-Posavina County and Croatia as a whole, respectively. These data revealed the specific morbidity in the Croatian endemic area and Brod-Posavina County to be 13.95-fold and 3.78-fold the morbidity recorded at the national level, respectively. The standardized morbidity ratio also showed the risk of developing UUC in the Croatian endemic area to be 3.75-fold the risk in Brod-Posavina County and 16.4-fold the risk in Croatia.
These results showed that specific mortality and morbidity as well as standardized morbidity ratio and standardized mortality ratio were higher in Croatian endemic area than in Brod-Posavina County and Croatia.
Vorheriger Artikel Postoperative quality of life after two different methods of tonsillectomy
Nächster Artikel Peginterferon alfa related psoriasis in a patient with acute hepatitis C and review of the literature
Literatur
1.
Cˇeovic´ S, Miletic´-Medved M. Epidemiological features of endemic nephropathy in the focal area of Brodska Posavina, Croatia. In: Cˇvorišc´ec D, Cˇeovic´ S, Stavljenic´-Rukavina A, editors. Endemic nephropathy in Croatia. Academia croatica scientiarum medicarum. Zagreb: Medicinska naklada; 1996. pp. 7–21.
2.
Miletic´-Medved M, Domijan AM, Peraica M. Recent data on endemic nephropathy and related urothelial tumors in Croatia. Wien Klin Wochenschr. 2005;117(17):604–9.CrossRefPubMed
3.
Cˇeovic´ S, Hrabar A, Radonic´ M. An etiological approach to Balkan endemic nephropathy based on the investigation of two genetically different populations. Nephron. 1985;40:175–9.CrossRefPubMed
4.
Castegnaro M, Canadas D, Vrabcheva T, et al. Balkan endemic nephopathy: role of ochratoxins A through biomarkers. Mol Nutr Food Res. 2006;50:519–29.CrossRefPubMed
5.
Voice TC, Long DT, Radovanovic´ Z, et al. Critical evaluation of environmental exposure agents suspected in the etiology of Balkan endemic nephropathy. Int J Occup Environ Health. 2006;12(4):369–76.PubMed
6.
Grollman AP, Shibutani S, Moriya M, et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci USA. 2007;104:12129–34.CrossRefPubMed
7.
Hranjec T, Kovacˇ A, Kos J, et al. Endemic nephropathy. The case for chronic poisoning by aristolochia. Croat Med J. 2005;46:116–25.PubMed
8.
Slade N, Moll UM, Brdar B, et al. p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy. Mutat Res. 2009;663:1–6.CrossRefPubMed
9.
Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 2008;74(2):158–69.CrossRefPubMed
10.
Schmeiser HH, Kucab JE, Arlt VM, et al. Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania. Environ Mol Mutagen. 2012;53:636–41. doi:10.1002/em.21732.CrossRefPubMed
11.
Cosyns JP, Jadoul M, Squifflet JP, et al. Chinese herb nephropathy. A clue to Balkan endemic nephropathy. Kidney Int. 1994;45:1680–88.CrossRefPubMed
12.
Grollman AP, Scarborough J, Jelakovic´ B. Aristolochic acid nephropathy: an environmental and iatrogenic disease. Adv Mol Toxicol. 2009;3:211–27.CrossRef
13.
Jelakovic´ B, Karanovic´ S, Vukovic´-Lela I, et al. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int. 2012;81:559–67.CrossRefPubMed
14.
Cvitkovic´ A, Vukovic´ Lela I, Edwards K, et al. Could disappearance of endemic (Balkan) nephropathy be expected in forthcoming decades. Kidney Blood Press Res. 2012;35:147–52.CrossRefPubMed
15.
Stefanovic´ V, Radovanovic´ Z. Balkan endemic nephropathy and associated urothelial cancer. Nat Clin Proct Urol. 2008;5(2):105–12.CrossRef
16.
Petronic´ VJ, Bukurov NS, Djokic´ MP, et al. Balkan endemic nephropathy and papillary transitional cell tumors of the renal pelvis and ureter. Kidney Int Suppl. 1991;34:S77–9.
17.
Markovic´ N, Ignjatovic´ I, Cukuranovic´ R, et al. Decreasing incidence of urothelial cancer in a Balkan endemic nephropathy region in Serbia. A surgery based study from 1969 to 1998. Pathol Biol (Paris). 2005;53:26–9.CrossRef
18.
Nikolic´ J. Altitude of settlements with the evidence of the endemic nephropathy and the upper urothelial tumors. In: Nikolic´ J, editor. Epidemic nephropathy and upper urothelial tumors. Beograd: Beograd AD; 2006. pp. 193–213.
19.
Stefanovic V, Polenakovic M, Toncheva D. Urothelial carcinoma associated with Balkan endemic nephropathy. A worldwide disease. Pathol Biol (Paris). 2011;59(5):286–91.CrossRef
20.
Stefanovic´ V, Toncheva D, Atanasova S, Polenakovic´ M. Etiology of Balkan endemic nephropathy and associated urothelial cancer. Am J Nephrol. 2006;26:1–11.CrossRefPubMed
21.
Basic-Jukic N, Hrsak-Puljic I, Kes P, et al. Renal transplantation in patients with Balkan endemic nephropathy. Transplant Proc. 2007;39(5):1432–5.CrossRefPubMed
22.
Last JM. editor. A dictionary of epidemiology. 4th edn. New York: Oxford University Press; 2001.
23.
Babuš V. Standardizirane i kumulativne stope. In: Babuš V, editor. Epidemiološke metode. Zagreb: Medicinska naklada; 2000. pp. 15–17.
24.
Colin P, Koenig P, Ouzzane A, et al. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int. 2009;104(10):1436–40.CrossRefPubMed
25.
Nikolic´ J, Djokic´ M, Ignjatovic I, Stefanovic V. Upper urothelial tumors in emigrants from Balkan endemic nephropathy areas in Serbia. Urol Int. 2006;77(3):240–4.CrossRefPubMed
26.
Cˇukuranovic´ R, Ignjatovic´ M, Stefanovic´ V. Urinary tract tumors and Balkan endemic nephropathy in the South Morava River Basin. Kidney Int Suppl. 1991;34:S80–4.PubMed
27.
Dimitrov PS, Simeonov VA, Stein AD. Balkan endemic nephropathy in Vratza, Bulgaria, 1964–1987, an epidemiologic analysis of population-based disease registers. Eur J Epidem. 2001;17:847–53.CrossRef
28.
Sostaric´ B, Vukelic´ M. Characteristics of urinary tract tumours in the area of Balkan endemicnephropathy in Croatia. IARC Sci Publ. 1991;(115):29–35.
29.
Belicza M, Demirovic´ A, Tomic´ K, et al. Comparison of occurrence of upper urinary tract carcinomas in the region with endemic villages and non-endemic nephropathy region in Croatia. Coll Antropol. 2008;32:1203–7.PubMed
30.
Radovanovic´ Z, Jankovic´ S, Jevremovic´ I. Incidence of tumors of urinary organs in a focus of Balkan endemic nephropathy. Kidney Int Suppl. 1991;34:75–6.
31.
Cukuranovic R, Ignjatovic I, Visnjic M, et al. Characteristics of upper urothelial carcinoma ina an area of Balkan endemic nephropathy in south Serbia. A fifty-year retrospective study. Tumori. 2010;96(5):674–9.PubMed
32.
Zivcic´-Cosic´ S, Grzetic´ M, Valencic´ M, et al. Urothelial cancer in patients with Endemic Balkan Nephropathy (EN) after renal transplantation. Ren Fail. 2007;29(7):861–5.CrossRefPubMed
33.
Cˇeovic´ S, Pleština R, Miletic´-Medved M, Stavljenic´ A, Mitar J, Vukelic´ M. Epidemiological aspects of Balkan endemic nephropathy in a typical focus in Yugoslavia. IARC Sci Publ. 1991;115:5–10.PubMed
34.
Bukvic´ D, Jankovic´ S, Markovic´-Denic´ Lj. Descriptive and epidemiologic characteristics of patients with malignant upper urothelial tumors in the endemic area of Lazarevac. Srp Arh Celok Lek. 1999;127(11–12):371–5.PubMed
35.
Charbit L, Gendreau MC, Mee S, Cukier J. Tumors of the upper urinary tract: 10 years of experience. J Urol. 1991;146:1243–6.PubMed
Metadaten
Titel
Upper urothelium carcinomas in Croatian endemic area
verfasst von
Ante Cvitković, PhD, MD
Igor Ivić-Hofman, MD
Dragana Jurić
Publikationsdatum
01.09.2013
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 17-18/2013
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-013-0412-5

Weitere Artikel der Ausgabe 17-18/2013

Erratum to: Acute health problems in African refugees

  • Erratum

Mitteilungen der Gesellschaft

  • mitteilungen der gesellschaft

mitteilungen der gesellschaft der ärzte in wien

  • mitteilungen der gesellschaft der ärzte in wien

Expression of β-catenin and cyclin D1 in Merkel cell carcinomas of the head and neck

  • original article

Peginterferon alfa related psoriasis in a patient with acute hepatitis C and review of the literature

  • case report

ÖGIM-abstracts September 2013

  • abstracts